123 related articles for article (PubMed ID: 32889248)
21. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
[TBL] [Abstract][Full Text] [Related]
22. Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro fertilization/intracytoplasmic sperm injection cycles.
Reljic M; Vlaisavljevic V; Gavric V; Kovacic B; Cizek-Sajko M
Fertil Steril; 2001 Mar; 75(3):539-43. PubMed ID: 11239538
[TBL] [Abstract][Full Text] [Related]
23. Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome.
Li X; Zeng C; Shang J; Wang S; Gao XL; Xue Q
Chin Med J (Engl); 2019 May; 132(10):1194-1201. PubMed ID: 30973445
[TBL] [Abstract][Full Text] [Related]
24. Do increased levels of progesterone and progesterone/estradiol ratio on the day of human chorionic gonadotropin affects pregnancy outcome in long agonist protocol in fresh in vitro fertilization/intracytoplasmic sperm injection cycles?
Singh N; Kaur SD; Malik N; Malhotra N; Vanamail P
J Hum Reprod Sci; 2015; 8(2):80-5. PubMed ID: 26157298
[TBL] [Abstract][Full Text] [Related]
25. The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles.
Cetinkaya ES; Berker B; Aytac R; Atabekoglu C; Sonmezer M; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):452-7. PubMed ID: 23932375
[TBL] [Abstract][Full Text] [Related]
26. Supraphysiologic estradiol is an independent predictor of low birth weight in full-term singletons born after fresh embryo transfer.
Pereira N; Elias RT; Christos PJ; Petrini AC; Hancock K; Lekovich JP; Rosenwaks Z
Hum Reprod; 2017 Jul; 32(7):1410-1417. PubMed ID: 28505290
[TBL] [Abstract][Full Text] [Related]
27. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
28. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
[TBL] [Abstract][Full Text] [Related]
29. Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.
Papaleo E; Corti L; Vanni VS; Pagliardini L; Ottolina J; De Michele F; La Marca A; Viganò P; Candiani M
Arch Gynecol Obstet; 2014 Jul; 290(1):169-76. PubMed ID: 24549270
[TBL] [Abstract][Full Text] [Related]
30. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
31. Correlation of serum estradiol level on the day of ovulation trigger with the reproductive outcome of intracytoplasmic sperm injection.
Siddhartha N; Reddy NS; Pandurangi M; Tamizharasi M; Radha V; Kanimozhi K
J Hum Reprod Sci; 2016; 9(1):23-7. PubMed ID: 27110074
[TBL] [Abstract][Full Text] [Related]
32. Does the elevated estradiol level on the day of human chorionic gonadotropin administration affect embryo quality among women undergoing in vitro fertilization?
Meng Y; Tong XH; Liu R; Zhang Y
Int J Gynaecol Obstet; 2021 Mar; 152(3):358-364. PubMed ID: 33118155
[TBL] [Abstract][Full Text] [Related]
33. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.
Sun B; Ma Y; Li L; Hu L; Wang F; Zhang Y; Dai S; Sun Y
Front Endocrinol (Lausanne); 2020; 11():615957. PubMed ID: 33542709
[TBL] [Abstract][Full Text] [Related]
34. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
Huang Y; Wang EY; Du QY; Xiong YJ; Guo XY; Yu YP; Sun YP
Reprod Biol Endocrinol; 2015 Aug; 13():82. PubMed ID: 26238449
[TBL] [Abstract][Full Text] [Related]
35. Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.
Elias RT; Pereira N; Artusa L; Kelly AG; Pasternak M; Lekovich JP; Palermo GD; Rosenwaks Z
J Assist Reprod Genet; 2017 Jun; 34(6):781-788. PubMed ID: 28444614
[TBL] [Abstract][Full Text] [Related]
36. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.
Scheffer JB; Scheffer BB; Carvalho RF; Aguiar AP; Lozano DHM; Labrosse J; Grynberg M
JBRA Assist Reprod; 2019 Aug; 23(3):239-245. PubMed ID: 30875186
[TBL] [Abstract][Full Text] [Related]
38. Progesterone elevation on the day of HCG administration may affect rescue ICSI.
Huang B; Li Z; Zhu L; Hu D; Liu Q; Zhu G; Zhang H
Reprod Biomed Online; 2014 Jul; 29(1):88-93. PubMed ID: 24813756
[TBL] [Abstract][Full Text] [Related]
39. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
[TBL] [Abstract][Full Text] [Related]
40. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
